EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease

Yibin Wang, Yundong Li, Xin Wang, Yaning Hou, Wei Deng, Meng Zheng, Yan Zou, Bingyang Shi iD

Advanced Materials · 2026

DOI: 10.1002/adma.202518697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yibin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory of Nanobiomedicine, the Second Clinical Medical College, School of Life Sciences, Henan University, Kaifeng, Hen…. Hauptthemen laut MEDLINE: Cannabidiol, Neuroinflammatory Diseases, Brain, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuroinflammation is a known etiopathogenic factor in neurodegenerative disease. While cannabidiol (CBD) has demonstrated anti‐inflammatory effects, unfavorable pharmacokinetics and poor blood‐brain barrier (BBB) permeability lead to low brain exposure. Here, we greatly improve the efficacy of CBD to treat neuroinflammation by incorporating CBD in a BBB‐permeable glucose nanoparticle (GNPs) that by design also incorporates tissue‐targeting moieties and uses reactive oxygen species responsive polymer to selectively target neuroinflammatory lesions. We achieved a high drug concentration over 20 times higher than naked cargo and demonstrate potent therapeutic effects in two mouse models of neuroinflammatory disease. Mechanistically, disease amelioration resulted from repolarizing microglia from the neurotoxic M1 to the neuroprotective M2 phenotype, leading to neuronal cell regeneration by enhanced secretion of brain derived neurotropic and anti‐inflammatory factors. Our approach for brain targeted CBD delivery may provide a versatile platform for treating other CNS disorders characterized by neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolNeuroinflammatory DiseasesBrainDrug Delivery SystemsDrug CarriersAnimalsBlood-Brain BarrierMiceGlucoseNanoparticlesMicrogliaAnti-Inflammatory AgentsHumans

Stichwörter der Autor:innen

blood brain barrierbrain deliverycannabidiolglucoseneuroinflammation

Substanzen

CannabidiolGlucoseAnti-Inflammatory AgentsDrug Carriers

Autor:innen und Institutionen

  • Henan International Joint Laboratory of Nanobiomedicine, the Second Clinical Medical College, School of Life Sciences, Henan University, Kaifeng, Henan, China.
  • School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Bingyang Shi

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Li, Y., Wang, X., Hou, Y., Deng, W., Zheng, M., Zou, Y., & Shi, B. (2026). Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease. Advanced Materials. https://doi.org/10.1002/adma.202518697

Vancouver

Wang Y, Li Y, Wang X, Hou Y, Deng W, Zheng M, et al. Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease. Advanced Materials. 2026. doi:10.1002/adma.202518697

BibTeX
@article{Wang2026,
  author = {Wang, Yibin and Li, Yundong and Wang, Xin and Hou, Yaning and Deng, Wei and Zheng, Meng and Zou, Yan and Shi, Bingyang},
  title = {Non‐Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202518697}
}
Kostenlos starten →